Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
This Quarter Return
+7.44%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$25.3B
AUM Growth
+$25.3B
(+9.9%)
Cap. Flow
+$1.54B
Cap. Flow
% of AUM
6.11%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| 1 |
Broadcom
AVGO
|
$456M |
| 2 |
Merck
MRK
|
$110M |
| 3 |
Boston Scientific
BSX
|
$80.9M |
| 4 |
AptarGroup
ATR
|
$55.7M |
| 5 |
Halozyme
HALO
|
$49M |
Top Sells
| 1 |
Edwards Lifesciences
EW
|
$48.6M |
| 2 |
WillScot Mobile Mini Holdings
WSC
|
$37M |
| 3 |
TE Connectivity
TEL
|
$26.7M |
| 4 |
NVIDIA
NVDA
|
$24M |
| 5 |
TSMC
TSM
|
$23.1M |
Sector Composition
| 1 | Technology | 34.79% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.68% |
| 4 | Industrials | 8.64% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $1.51B | 5.98% | 6,493,213 -94,614 | -1% | -$22M |
|
2
Microsoft
MSFT
$3.77T
| $1.44B | 5.7% | 3,351,220 +41,589 | +1% | +$17.9M |
|
|
3
NVIDIA
NVDA
$4.24T
| $1.34B | 5.28% | 10,994,643 -197,248 | -2% | -$24M |
|
4
Eli Lilly
LLY
$657B
| $680M | 2.69% | 767,025 +8,926 | +1% | +$7.91M |
|
5
Meta Platforms (Facebook)
META
$1.86T
| $620M | 2.45% | 1,082,285 +56,362 | +5% | +$32.3M |
|
6
UnitedHealth
UNH
$281B
| $513M | 2.03% | 876,671 +8,621 | +1% | +$5.04M |
|
|
7
Broadcom
AVGO
$1.4T
| $511M | 2.02% | 2,963,813 +2,643,845 | +826% | +$456M |
|
8
Alphabet (Google) Class A
GOOGL
$2.57T
| $466M | 1.84% | 2,808,189 -63,252 | -2% | -$10.5M |
|
|
9
Alphabet (Google) Class C
GOOG
$2.58T
| $439M | 1.74% | 2,628,176 +115,716 | +5% | +$19.3M |
|
|
10
Merck
MRK
$210B
| $355M | 1.41% | 3,130,042 +967,462 | +45% | +$110M |
|
11
Mastercard
MA
$538B
| $310M | 1.22% | 627,011 +43,679 | +7% | +$21.6M |
|
12
JPMorgan Chase
JPM
$829B
| $266M | 1.05% | 1,263,820 +34,760 | +3% | +$7.33M |
|
13
Johnson & Johnson
JNJ
$427B
| $243M | 0.96% | 1,501,599 +26,672 | +2% | +$4.32M |
|
14
Thermo Fisher Scientific
TMO
$186B
| $243M | 0.96% | 392,981 +2,320 | +0.6% | +$1.44M |
|
15
AbbVie
ABBV
$372B
| $226M | 0.9% | 1,145,941 +16,817 | +1% | +$3.32M |
|
16
Berkshire Hathaway Class B
BRK.B
$1.09T
| $214M | 0.84% | 464,057 +9,389 | +2% | +$4.32M |
|
|
17
Boston Scientific
BSX
$156B
| $199M | 0.79% | 2,371,407 +965,080 | +69% | +$80.9M |
|
18
Abbott
ABT
$231B
| $193M | 0.76% | 1,692,554 +77,091 | +5% | +$8.79M |
|
19
Vertex Pharmaceuticals
VRTX
$100B
| $191M | 0.76% | 411,515 -4,866 | -1% | -$2.26M |
|
20
Intuit
INTU
$186B
| $189M | 0.75% | 303,931 +2,060 | +0.7% | +$1.28M |
|
21
Visa
V
$683B
| $158M | 0.62% | 573,024 +15,176 | +3% | +$4.17M |
|
22
Jack Henry & Associates
JKHY
$11.9B
| $152M | 0.6% | 863,800 +66,600 | +8% | +$11.8M |
|
23
Procter & Gamble
PG
$368B
| $148M | 0.59% | 855,587 +17,785 | +2% | +$3.08M |
|
24
Fluence Energy
FLNC
$969M
| $145M | 0.57% | 6,376,024 +2,047,063 | +47% | +$46.5M |
|
25
Service Corp International
SCI
$11.1B
| $143M | 0.57% | 1,810,148 +61,838 | +4% | +$4.88M |
|